1. Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea
2. Department of Pharmacy, Chungbuk National University College of Pharmacy, Cheongju, Korea
3. Division of Drug Evaluation, NDDC, Oseong Medical Innovation Foundation, Cheongju, Korea
4. Research Group for Biomimetic Advanced Technology, Korea Institute of Toxicology, Daejeon, Korea
5. R&D Unit, Amorepacific Corporation, Yongin, Korea
6. Department of Stem Cell Biology, School of Medicine, Konkuk University, Seoul, Korea
7. Department of Human and Environmental Toxicology, University of Science and Technology, Daejeon, Korea